المؤلفون: Rao, Sheela, Anandappa, Gayathri, Capdevila, Jaume, Dahan, Laëtitia, Evesque, Ludovic, Kim, Stefano, Saunders, Mark M.P., Gilbert, Duncan D.C., Jensen, Lars Henrik, Samalin, Emmanuelle, Spindler, Karen Lise Garm K.L., Tamberi, Stefano, Demols, Anne, Guren, Marianne M.G., Arnold, Dirk, Fakih, Marwan, Kayyal, T., Cornfeld, M., Tian, C., Catlett, M., Smith, M., Spano, Jean Philippe

المصدر: ESMO Open, 7 (4

مصطلحات موضوعية: Généralités, anal cancer, clinical trial, INCMGA00012, PD-(L)1 inhibitor, phase II, retifanlimab

وصف الملف: 1 full-text file(s): application/pdf

Relation: uri/info:doi/10.1016/j.esmoop.2022.100529; uri/info:pii/S2059702922001508; uri/info:pmid/35816951; uri/info:scp/85133951152; https://dipot.ulb.ac.be/dspace/bitstream/2013/349700/1/doi_333344.pdf; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/349700

الاتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/349700
https://dipot.ulb.ac.be/dspace/bitstream/2013/349700/1/doi_333344.pdf